Understanding COVID-19 IgG Antibodies: Normal vs Optimal Ranges

?What is COVID-19 IgG Antibodies?

SARS-CoV-2 IgG antibodies are immunoglobulins produced by the immune system in response to COVID-19 infection or vaccination. Quantitative IgG testing measures the concentration of antibodies against specific viral antigens (typically spike protein or nucleocapsid), providing information about immune status and protection level.

!Why It Matters

COVID-19 IgG antibody levels correlate with protection against reinfection and severe disease, though the exact threshold for protection varies. Antibodies wane over time, informing booster vaccination decisions. Nucleocapsid-specific IgG indicates prior infection, while spike-only antibodies may result from vaccination. Immunocompromised patients are tested to verify adequate vaccine response.

Reference Ranges

Lab normal ranges may vary between laboratories. Optimal and longevity targets are based on research literature and should be interpreted with your physician.

Symptoms of Imbalance

• Seropositive individuals may be asymptomatic or have had prior infection
• Absence of antibodies despite vaccination may indicate impaired immune response

How to Improve Your Levels

• 1Vaccination provides robust spike protein IgG responses
• 2Booster doses restore waning antibody levels
• 3Immunocompromised patients may require enhanced vaccination schedules

When to Test

Post-vaccination immune response assessment; prior infection confirmation; immunocompromised patient vaccination monitoring.

Related Biomarkers